These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19751863)

  • 21. Once-a-month injectable contraceptives.
    d'Arcangues C
    World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statement on injectable contraception. Revised.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1992 Dec; 26(6):4-6. PubMed ID: 12346921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
    Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate.
    Beksinska ME; Smit JA; Kleinschmidt I; Rees HV; Farley TM; Guidozzi F
    Contraception; 2003 Nov; 68(5):339-43. PubMed ID: 14636937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.
    Polis CB; Phillips SJ; Curtis KM; Westreich DJ; Steyn PS; Raymond E; Hannaford P; Turner AN
    Contraception; 2014 Oct; 90(4):360-90. PubMed ID: 25183264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
    Nanda K; Callahan R; Taylor D; Wang M; Agot K; Jenkins D; Van Damme L; Dorflinger L;
    Contraception; 2016 Jul; 94(1):40-7. PubMed ID: 26972780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.
    Beksinska ME; Kleinschmidt I; Smit JA; Farley TM
    Contraception; 2009 May; 79(5):345-9. PubMed ID: 19341845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.
    Matubu AT; Hillier SL; Meyn LA; Stoner KA; Mhlanga F; Mbizvo M; Maramba A; Chirenje ZM; Achilles SL
    Am J Reprod Immunol; 2021 Jul; 86(1):e13405. PubMed ID: 33609312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postabortal contraception with norethisterone enanthate injections.
    Lähteenmäki P; Toivonen J; Lähteenmäki PL
    Contraception; 1983 Jun; 27(6):553-62. PubMed ID: 6413130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting injectable contraception with depot medroxyprogesterone acetate.
    Kaunitz AM
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.
    Matubu A; Hillier SL; Meyn LA; Stoner KA; Mhlanga F; Mbizvo M; Maramba A; Chirenje ZM; Achilles SL
    Am J Reprod Immunol; 2020 Mar; 83(3):e13210. PubMed ID: 31729087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
    JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injectable contraceptives.
    Toppozada M
    Contracept Deliv Syst; 1982 Apr; 3(2):161-70. PubMed ID: 12338171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
    AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injectable contraceptives: safe and effective.
    IPPF Med Bull; 1982 Feb; 16(1):3-4. PubMed ID: 12264296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.